1. Home
  2. NEON vs BCDA Comparison

NEON vs BCDA Comparison

Compare NEON & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

N/A

Current Price

$0.95

Market Cap

15.1M

Sector

Technology

ML Signal

N/A

Logo BioCardia Inc.

BCDA

BioCardia Inc.

N/A

Current Price

$2.24

Market Cap

14.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEON
BCDA
Founded
1997
N/A
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1M
14.1M
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
NEON
BCDA
Price
$0.95
$2.24
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$25.00
AVG Volume (30 Days)
98.8K
230.2K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
$479,000.00
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.75
52 Week High
$25.90
$2.29

Technical Indicators

Market Signals
Indicator
NEON
BCDA
Relative Strength Index (RSI) N/A 62.26
Support Level N/A $0.80
Resistance Level N/A $1.29
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.02
Stochastic Oscillator 0.00 99.95

Price Performance

Historical Comparison
NEON
BCDA

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: